Bank of New York Mellon’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.93B | Buy |
15,263,929
+210,778
| +1% | +$27.8M | 0.32% | 52 |
|
|
2026
Q1 | $2.1B | Sell |
15,053,151
-162,233
| -1% | -$22.7M | 0.39% | 41 |
|
|
2025
Q4 | $1.87B | Buy |
15,215,384
+967,031
| +7% | +$118M | 0.33% | 52 |
|
|
2025
Q3 | $1.58B | Buy |
14,248,353
+516,437
| +4% | +$58.7M | 0.28% | 61 |
|
|
2025
Q2 | $1.52B | Sell |
13,731,916
-2,071,670
| -13% | -$220M | 0.29% | 65 |
|
|
2025
Q1 | $1.77B | Sell |
15,803,586
-953,055
| -6% | -$98.3M | 0.35% | 52 |
|
|
2024
Q4 | $1.55B | Buy |
16,756,641
+2,825,896
| +20% | +$254M | 0.29% | 60 |
|
|
2024
Q3 | $1.17B | Sell |
13,930,745
-207,407
| -1% | -$15.8M | 0.22% | 94 |
|
|
2024
Q2 | $970M | Sell |
14,138,152
-535,335
| -4% | -$35.7M | 0.18% | 104 |
|
|
2024
Q1 | $1.07B | Sell |
14,673,487
-825,419
| -5% | -$63.5M | 0.21% | 96 |
|
|
2023
Q4 | $1.26B | Buy |
15,498,906
+114,379
| +0.7% | +$8.9M | 0.25% | 76 |
|
|
2023
Q3 | $1.15B | Sell |
15,384,527
-2,068,395
| -12% | -$159M | 0.25% | 79 |
|
|
2023
Q2 | $1.35B | Buy |
17,452,922
+440,718
| +3% | +$35.1M | 0.28% | 67 |
|
|
2023
Q1 | $1.41B | Buy |
17,012,204
+466,595
| +3% | +$38.6M | 0.31% | 62 |
|
|
2022
Q4 | $1.42B | Buy |
16,545,609
+1,124,173
| +7% | +$89M | 0.32% | 59 |
|
|
2022
Q3 | $951M | Buy |
15,421,436
+1,987,058
| +15% | +$125M | 0.23% | 92 |
|
|
2022
Q2 | $830M | Buy |
13,434,378
+733,944
| +6% | +$45.4M | 0.19% | 103 |
|
|
2022
Q1 | $755M | Sell |
12,700,434
-259,813
| -2% | -$16.6M | 0.15% | 125 |
|
|
2021
Q4 | $941M | Buy |
12,960,247
+299,457
| +2% | +$20.6M | 0.17% | 115 |
|
|
2021
Q3 | $884M | Sell |
12,660,790
-28,960
| -0.2% | -$2.03M | 0.17% | 111 |
|
|
2021
Q2 | $874M | Sell |
12,689,750
-365,837
| -3% | -$24.4M | 0.17% | 113 |
|
|
2021
Q1 | $844M | Sell |
13,055,587
-750,945
| -5% | -$48.4M | 0.17% | 111 |
|
|
2020
Q4 | $804M | Sell |
13,806,532
-2,625,006
| -16% | -$158M | 0.18% | 105 |
|
|
2020
Q3 | $1.04B | Sell |
16,431,538
-422,143
| -3% | -$29.3M | 0.26% | 78 |
|
|
2020
Q2 | $1.3B | Sell |
16,853,681
-2,072,078
| -11% | -$159M | 0.35% | 62 |
|
|
2020
Q1 | $1.41B | Sell |
18,925,759
-10,142,225
| -35% | -$701M | 0.47% | 42 |
|
|
2019
Q4 | $1.89B | Buy |
29,067,984
+870,944
| +3% | +$56.7M | 0.49% | 36 |
|
|
2019
Q3 | $1.79B | Sell |
28,197,040
-210,504
| -0.7% | -$13.8M | 0.49% | 38 |
|
|
2019
Q2 | $1.92B | Sell |
28,407,544
-832,136
| -3% | -$54.7M | 0.52% | 32 |
|
|
2019
Q1 | $1.9B | Buy |
29,239,680
+710,832
| +2% | +$47.2M | 0.53% | 32 |
|
|
2018
Q4 | $1.78B | Sell |
28,528,848
-2,821,866
| -9% | -$197M | 0.56% | 30 |
|
|
2018
Q3 | $2.42B | Buy |
31,350,714
+398,060
| +1% | +$30.1M | 0.62% | 25 |
|
|
2018
Q2 | $2.19B | Buy |
30,952,654
+3,237,123
| +12% | +$229M | 0.6% | 27 |
|
|
2018
Q1 | $2.09B | Sell |
27,715,531
-2,827,397
| -9% | -$225M | 0.58% | 28 |
|
|
2017
Q4 | $2.19B | Buy |
30,542,928
+446,263
| +1% | +$33.9M | 0.58% | 25 |
|
|
2017
Q3 | $2.44B | Sell |
30,096,665
-784,740
| -3% | -$60M | 0.67% | 18 |
|
|
2017
Q2 | $2.19B | Buy |
30,881,405
+310,607
| +1% | +$20.7M | 0.62% | 24 |
|
|
2017
Q1 | $2.08B | Buy |
30,570,798
+2,727,063
| +10% | +$192M | 0.57% | 26 |
|
|
2016
Q4 | $1.99B | Buy |
27,843,735
+1,056,805
| +4% | +$78.6M | 0.57% | 27 |
|
|
2016
Q3 | $2.12B | Buy |
26,786,930
+169,701
| +0.6% | +$13.8M | 0.63% | 21 |
|
|
2016
Q2 | $2.22B | Buy |
26,617,229
+1,023,299
| +4% | +$90.8M | 0.68% | 21 |
|
|
2016
Q1 | $2.35B | Sell |
25,593,930
-827,929
| -3% | -$74.7M | 0.71% | 20 |
|
|
2015
Q4 | $2.67B | Buy |
26,421,859
+360,747
| +1% | +$37.5M | 0.81% | 16 |
|
|
2015
Q3 | $2.56B | Sell |
26,061,112
-2,061,292
| -7% | -$229M | 0.78% | 15 |
|
|
2015
Q2 | $3.29B | Sell |
28,122,404
-1,883,369
| -6% | -$206M | 0.91% | 9 |
|
|
2015
Q1 | $2.94B | Buy |
30,005,773
+2,940,253
| +11% | +$299M | 0.77% | 15 |
|
|
2014
Q4 | $2.55B | Buy |
27,065,520
+5,135,291
| +23% | +$531M | 0.67% | 19 |
|
|
2014
Q3 | $2.33B | Buy |
21,930,229
+234,364
| +1% | +$22.9M | 0.63% | 26 |
|
|
2014
Q2 | $1.8B | Buy |
21,695,865
+301,498
| +1% | +$23.5M | 0.48% | 34 |
|
|
2014
Q1 | $1.52B | Sell |
21,394,367
-25,628
| -0.1% | -$2.01M | 0.41% | 46 |
|
|
2013
Q4 | $1.61B | Sell |
21,419,995
-60,026
| -0.3% | -$4.18M | 0.45% | 41 |
|
|
2013
Q3 | $1.35B | Buy |
21,480,021
+271,800
| +1% | +$16.2M | 0.4% | 47 |
|
|
2013
Q2 | $1.09B | Buy |
+21,208,221
| New | +$1.11B | 0.34% | 55 |
|
Other funds holding GILD
N
Bank of New York Mellon's GILD Position: Q2 2026 in Review
Bank of New York Mellon increased its Gilead Sciences (GILD) stake by 1.4% in Q2 2026, buying an estimated $27.8M and bringing the position to 15,263,929 shares worth $1.93B. The position accounts for 0.32% of the portfolio, ranked #52.
Bank of New York Mellon first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $3.29B in Q2 2015. 1,725 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Bank of New York Mellon held 15,263,929 shares of Gilead Sciences worth $1.93B as of Q2 2026.
- Bank of New York Mellon bought 210,778 Gilead Sciences shares in Q2 2026, an estimated $27.8M.
- Gilead Sciences made up 0.32% of Bank of New York Mellon's portfolio in Q2 2026, its #52 holding.
- Bank of New York Mellon first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
- Bank of New York Mellon's Gilead Sciences position peaked at $3.29B in Q2 2015.
- 1,725 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.